AT
Astria Therapeutics, Inc.
ATXS · NASDAQ
$12.78 -0.88% (-$0.11)
Market Cap $735.8M
P/E Ratio -
Div. Yield -
ROE 45.01%
Bulios Fair Price
$9.17
28.2% downside
Trenutna cena
$12.78
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ATXS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
3/9Valuation
32 /100
Expensive P/B 3.15x
P/S 1,042.24x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 83.64%
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Net margin 17,568.00%
Op. margin 19,335.70%
FCF margin 17,042.90%
Quality
0 /100
Poor ROE 45.01%
ROA 45.62%
Asset turnover 0.00x
Debt
98 /100
Low Current ratio 10.78x
Net debt/EBITDA 0.68x
Debt/Equity 0.02x
Stability
1 /100
Unstable EPS volatility 94.31%
Profitable years 0
Beta 0.02x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ATXS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jill C. Milne
Employees
78
Headquarters
Boston